Clinical Trial Update: Early Feasibility Study of the Nervive VitalFlow Stimulation for Acute Ischemic Stroke Patients [NA]

View source ↗

Summary

The Nervive VitalFlow stimulation early feasibility study for acute ischemic stroke has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Nervive, Inc. | Conditions: Acute Stroke | NA | Status: WITHDRAWN